MB, Levis & Associates’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$24.8K 293
2025
Q2
$24.8K Hold
100
0.01% 154
2025
Q1
$26.5K Hold
100
0.01% 151
2024
Q4
$25.4K Hold
100
0.01% 148
2024
Q3
$28.2K Hold
100
0.01% 146
2024
Q2
$26.6K Hold
100
0.01% 147
2024
Q1
$27.1K Hold
100
0.01% 145
2023
Q4
$25.1K Sell
100
-170
-63% -$40.3K 0.01% 147
2023
Q3
$63.4K Buy
270
+1
+0.4% +$244 0.04% 101
2023
Q2
$65.9K Hold
269
0.04% 100
2023
Q1
$64.2K Hold
269
0.04% 101
2022
Q4
$66.6K Buy
+269
New +$65.2K 0.05% 92

Other funds holding VHT

MB, Levis & Associates's VHT Position: Q3 2025 in Review

MB, Levis & Associates sold out of Vanguard Health Care ETF (VHT) in Q3 2025, closing a stake of 100 shares — an estimated $24.8K sold.

MB, Levis & Associates first reported a position in VHT in Q4 2022 and held it in 11 quarters. The position peaked at $66.6K in Q4 2022. 1,013 funds tracked by Wall St. Rank hold VHT as of Q3 2025.

  • MB, Levis & Associates reported no remaining Vanguard Health Care ETF position as of Q3 2025 after selling out during the quarter.
  • MB, Levis & Associates sold 100 Vanguard Health Care ETF shares in Q3 2025, an estimated $24.8K.
  • MB, Levis & Associates first reported a position in Vanguard Health Care ETF in Q4 2022 and held it in 11 quarters.
  • MB, Levis & Associates's Vanguard Health Care ETF position peaked at $66.6K in Q4 2022.
  • 1,013 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.